Advertorial

Avacta expands following Aptuscan acquisition

Posted: 29 June 2012 | | No comments yet

Avacta Group has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space…

Alastair Smith, CEO of Avacta Group plc, alongside Tim Munns, Director of Wharfedale Property Management Ltd., managers of the Thorp Arch Estate, outside the Avacta building

Alastair Smith, CEO of Avacta Group plc, alongside Tim Munns, Director of Wharfedale Property Management Ltd., managers of the Thorp Arch Estate, outside the Avacta building

Avacta Group – a UK-based healthcare technology and consumables business – has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space. The move, which follows the recent acquisition of affinity reagents specialist Aptuscan, brings together the entire Avacta Group on the same site.

Alastair Smith, CEO of Avacta Group plc, alongside Tim Munns, Director of Wharfedale Property Management Ltd., managers of the Thorp Arch Estate, outside the Avacta building

Alastair Smith, CEO of Avacta Group plc, alongside Tim Munns, Director of Wharfedale Property Management Ltd., managers of the Thorp Arch Estate, outside the Avacta building

The new facilities, which include purpose built laboratories, are at Avacta’s existing Thorp Arch Estate premises in Wetherby, UK, and have been taken on to accommodate the Company’s current rapid expansion. Alastair Smith, Chief Executive of Avacta, commented: “Our core businesses are seeing strong growth, and recent funding, together with the acquisition of Aptuscan, will ensure we are able to accelerate our existing product development pipeline. Thorp Arch Estate is an ideal location for biotechnology enterprises, with excellent transport connections, and we are enthusiastic about plans to create a wider science park facility here.”

For more information, visit www.avactaanalytical.com

Related organisations

Related people